The effectivness of Dracocephalum Kotschyi on irritable bowel syndrome (IBS)

Irritable bowel syndrome Explanation based on Iranian Tradition Medicine and The effectivness of Dracocephalum Kotschyi on quality of life and IBS Severity in patient (18-50 years old) with diarrhea-predominant or mixed type irritable bowel syndrome

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20180823040854N1

Enrollment

Registered

2019-07-30

Start date

2018-04-07

Completion date

Unknown

Last updated

2019-10-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Irritable Bowel Syndrome. Irritable bowel syndrome

Interventions

Intervention 1: Intervention group :Hydro alcohol extract capsule of Dracocephalum Kotschyi manufactured in the School of Pharmacy of Isfahan University of Medical Sciences, three times a day each ti

Eligibility

Sex/Gender

All

Age

18 Years to 50 Years

Inclusion criteria

Inclusion criteria: Definite diagnosis of irritable bowel syndrome based on Rome 3 criteria and confirmation of diagnosis by a gastrointestinal specialist Patients with irritable bowel syndrome of diarrhea type or a mixed type Patients with moderate severityof irritable bowel syndrome Within the age group of 18-50 years Not being afflicted with psychiatric disorders Informed consent for study Having a normal colonoscopy and para-clinic evidences of intestinal cancer and other related differential diagnosis Not taking any other drug in order to treat IBS disorder

Exclusion criteria

Exclusion criteria: Be pregnant from the beginning History of severe sensitivity reactions to aromatic substances

Design outcomes

Primary

Measure	Time frame
Life quality of patients afflicted with irritable bowel syndrome and its areas. Timepoint: -In the beginning of the study (before the intervention begins) and one month after the beginning of taking Dracocephalum Kotschyi and one month after cutting its consumption. Method of measurement: The questionnaire of life quality of patients afflicted with irritable bowel syndrome.;Severity in patient of Irritable bowel syndrome. Timepoint: -Determination of severity of irritable bowel syndrome symptoms in the beginning of the study (before the intervention begins) and one month after the beginning of taking Dracocephalum Kotschyi and one month after cutting its consumption. Method of measurement: -The questionnaire and index of severity of irritable bowel syndrome symptoms.	—

Measure

Time frame

Life quality of patients afflicted with irritable bowel syndrome and its areas. Timepoint: -In the beginning of the study (before the intervention begins) and one month after the beginning of taking Dracocephalum Kotschyi and one month after cutting its consumption. Method of measurement: The questionnaire of life quality of patients afflicted with irritable bowel syndrome.;Severity in patient of Irritable bowel syndrome. Timepoint: -Determination of severity of irritable bowel syndrome symptoms in the beginning of the study (before the intervention begins) and one month after the beginning of taking Dracocephalum Kotschyi and one month after cutting its consumption. Method of measurement: -The questionnaire and index of severity of irritable bowel syndrome symptoms.

—

Secondary

Measure	Time frame
Life quality mark in those afflicted with irritable bowel syndrome. Timepoint: In the beginning of the study (before the intervention begins) and one month after the beginning of taking Dracocephalum Kotschyi and one month after cutting its consumption. Method of measurement: The quality of life in those afflicted with irritable bowel syndrome.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactParisa Heydari

Esfahan University of Medical Sciences

parisaa_sooresh@yahoo.com+98 31 3668 8138

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026